CA 19-9 Blood Test: Meaning, Levels, and Interpretation
The CA 19-9 blood test measures cancer antigen 19-9, a tumor marker linked to pancreatic and biliary diseases. Normal levels are 0–37 U/mL. Elevated CA 19-9 levels may indicate cancer, inflammation, or bile duct blockage, while low levels are typical in healthy individuals. This test is mainly used to monitor treatment and disease progression rather than for screening.
Contents
Result interpretation CA 19-9
What your result means based on common reference ranges
CA 19-9 levels within 0–37 U/mL suggest no active tumor growth or significant pancreatic or biliary inflammation.
Mildly elevated CA 19-9 levels may indicate benign conditions such as pancreatitis, gallstones, or liver dysfunction.
Severely elevated CA 19-9 levels above 100 U/mL strongly suggest pancreatic cancer or advanced biliary tract malignancy.
Low CA 19-9 levels are normal and may also occur in individuals with Lewis antigen-negative genetic status.
🔬 Check your value CA 19-9
Enter your result and get a personalized interpretation
What is CA 19-9?
CA 19-9 is a carbohydrate antigen produced by cells in the pancreas and bile ducts, released into the bloodstream in higher amounts during disease. This blood test is commonly used in oncology to monitor pancreatic cancer and other gastrointestinal malignancies. Elevated levels may also occur in benign conditions such as pancreatitis, cholestasis, or liver cirrhosis. The CA 19-9 level is most useful when tracked over time alongside markers like CEA and bilirubin. It helps assess tumor response to treatment, detect recurrence, and evaluate pancreatic function and biliary obstruction.
Reference ranges
Causes of abnormal values
Causes of low CA 19-9
- • Normal health — absence of inflammation or tumor activity
- • Successful cancer treatment — reduced tumor burden lowers CA 19-9 levels
- • Lewis antigen-negative status — genetic inability to produce CA 19-9
- • Early-stage disease — insufficient tumor activity for detectable elevation
Causes of high CA 19-9
- • Pancreatic cancer — tumor cells produce large amounts of CA 19-9 antigen
- • Bile duct obstruction — blocked ducts cause antigen accumulation in blood
- • Pancreatitis — inflammation releases CA 19-9 from damaged pancreatic tissue
- • Liver cirrhosis — impaired clearance increases circulating antigen levels
- • Cholangitis — bile duct inflammation raises production and reduces elimination
- • Gallstones — mechanical blockage elevates CA 19-9 levels
- • Ovarian tumors — some tumors produce this antigen in smaller quantities
CA 19-9 in combination with other markers
Possible symptoms
- •Jaundice with yellowing of skin and eyes
- •Upper abdominal pain radiating to the back
- •Unexplained weight loss and appetite reduction
- •Dark urine due to bilirubin accumulation
- •Nausea and digestive discomfort
When to see a doctor
Consult a doctor if your CA 19-9 blood test exceeds 37 U/mL or shows a rising trend over time. Immediate evaluation is needed if high levels are combined with jaundice, abdominal pain, or unexplained weight loss.
What to do if abnormal
- Repeat the test in 2–4 weeks to assess trends
- Check liver function and bilirubin levels
- Schedule imaging (ultrasound, CT, or MRI)
- Review medications and supplements with your doctor
- Stay calm and interpret results with clinical context
The information on this page is intended for general understanding of test results and does not replace medical consultation. Accurate interpretation requires considering other blood markers and individual factors.
Content is based on medical literature and used within the PulseBook analytical system.
Want to understand your full health picture?
PulseBook analyzes all your results together, remembers your history and answers questions 24/7
Try for free →Fast • Sign in with Google • Free